纳米载体
牙周炎
背景(考古学)
药物输送
PLGA公司
药品
医学
生物膜
牙科
药理学
纳米技术
材料科学
生物
纳米颗粒
古生物学
遗传学
细菌
作者
Emilio A. Cafferata,Carla Álvarez,Karla Diaz,Miguel Maureira,Gustavo Monasterio,Fermín E. González,Cristian Covarrubias,Rolando Vernal
出处
期刊:Oral Diseases
[Wiley]
日期:2018-12-19
卷期号:25 (8): 1866-1878
被引量:40
摘要
Abstract Periodontitis is an inflammatory disease, in which the host immuno‐inflammatory response against the dysbiotic subgingival biofilm leads to the breakdown of periodontal tissues. Most of the available treatments seem to be effective in the short‐term; nevertheless, permanent periodical controls and patient compliance compromise long‐term success. Different strategies have been proposed for the modulation of the host immune response as potential therapeutic tools to take a better care of most susceptible periodontitis patients, such as drug local delivery approaches. Though, maintaining an effective drug concentration for a prolonged period of time has not been achieved yet. In this context, advanced drug delivery strategies using biodegradable nanocarriers have been proposed to avoid toxicity and frequency‐related problems of treatment. The versatility of distinct nanocarriers allows the improvement of their loading and release capabilities and could be potentially used for microbiological control, periodontal regeneration, and/or immunomodulation. In the present review, we revise and discuss the most frequent biodegradable nanocarrier strategies proposed for the treatment of periodontitis, including polylactic‐co‐glycolic acid (PLGA), chitosan, and silica‐derived nanoparticles, and further suggest novel therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI